{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:46:06Z","timestamp":1791549966556,"version":"4.3.4"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Beijing Hospitals Authority \"Dengfeng\" talent training plan","award":["DFL20220101"],"award-info":[{"award-number":["DFL20220101"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2507400"],"award-info":[{"award-number":["2023YFC2507400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s10620-024-08565-9","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T11:02:57Z","timestamp":1722855777000},"page":"3134-3146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Nonsteroidal Anti-inflammatory Drugs for the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis"],"prefix":"10.1007","volume":"69","author":[{"given":"Jiaxuan","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengcun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,5]]},"reference":[{"key":"8565_CR1","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3109\/00365519709084587","volume":"57","author":"A M\u00e4kel\u00e4","year":"1997","unstructured":"M\u00e4kel\u00e4 A, Kuusi T, Schr\u00f6der T. Inhibition of serum phospholipase-A2 in acute pancreatitis by pharmacological agents in vitro. Scand J Clin Lab Invest 1997;57:401\u2013407.","journal-title":"Scand J Clin Lab Invest"},{"key":"8565_CR2","first-page":"522","volume":"40","author":"V Gross","year":"1993","unstructured":"Gross V, Leser HG, Heinisch A, Sch\u00f6lmerich J. Inflammatory mediators and cytokines\u2013new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterology 1993;40:522\u2013530.","journal-title":"Hepatogastroenterology"},{"key":"8565_CR3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1080\/00365521.2019.1623306","volume":"54","author":"L Li","year":"2019","unstructured":"Li L, Liu M, Zhang T, Jia Y, Zhang Y, Yuan H, et al. Indomethacin down-regulating HMGB1 and TNF-\u03b1 to prevent pancreatitis after endoscopic retrograde cholangiopancreatography. Scand J Gastroenterol 2019;54:793\u2013799.","journal-title":"Scand J Gastroenterol"},{"key":"8565_CR4","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/jgh.15012","volume":"35","author":"C Geng","year":"2020","unstructured":"Geng C, Li X, Li Y, Song S, Wang C. Nonsteroidal anti-inflammatory drugs alleviate severity of post-endoscopic retrograde cholangiopancreatography pancreatitis by inhibiting inflammation and reducing apoptosis. J Gastroenterol Hepatol 2020;35:896\u2013904.","journal-title":"J Gastroenterol Hepatol"},{"key":"8565_CR5","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/S0016-5085(03)00384-6","volume":"124","author":"B Murray","year":"2003","unstructured":"Murray B, Carter R, Imrie C, Evans S, O\u2019Suilleabhain C. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 2003;124:1786\u20131791.","journal-title":"Gastroenterology"},{"key":"8565_CR6","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/j.1572-0241.2007.01165.x","volume":"102","author":"R Sotoudehmanesh","year":"2007","unstructured":"Sotoudehmanesh R, Khatibian M, Kolahdoozan S, Ainechi S, Malboosbaf R, Nouraie M. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP. Am J Gastroenterol 2007;102:978\u2013983.","journal-title":"Am J Gastroenterol"},{"key":"8565_CR7","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1111\/j.1440-1746.2007.05096.x","volume":"23","author":"M Khoshbaten","year":"2008","unstructured":"Khoshbaten M, Khorram H, Madad L, Ehsani Ardakani MJ, Farzin H, Zali MR. Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis. J Gastroenterol Hepatol 2008;23:e11-16.","journal-title":"J Gastroenterol Hepatol"},{"key":"8565_CR8","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1056\/NEJMoa1111103","volume":"366","author":"BJ Elmunzer","year":"2012","unstructured":"Elmunzer BJ, Scheiman JM, Lehman GA, Chak A, Mosler P, Higgins PD, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med 2012;366:1414\u20131422.","journal-title":"N Engl J Med"},{"key":"8565_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1055\/a-1075-4080","volume":"52","author":"JM Dumonceau","year":"2020","unstructured":"Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2020;52:127\u2013149.","journal-title":"Endoscopy"},{"key":"8565_CR10","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1001\/jama.2014.5220","volume":"311","author":"PB Cotton","year":"2014","unstructured":"Cotton PB, Durkalski V, Romagnuolo J, et al. Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISOD randomized clinical trial. Jama 2014;311:2101\u20132109.","journal-title":"Jama"},{"key":"8565_CR11","doi-asserted-by":"publisher","first-page":"e600","DOI":"10.1016\/j.cgh.2020.11.008","volume":"20","author":"ZL Smith","year":"2022","unstructured":"Smith ZL, Shah R, Elmunzer BJ, Chak A. The Next EPISOD: Trends in Utilization of Endoscopic Sphincterotomy for Sphincter of Oddi Dysfunction from 2010\u20132019. Clin Gastroenterol Hepatol 2022;20:e600\u2013e609.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8565_CR12","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/jgh.14948","volume":"35","author":"T Katoh","year":"2020","unstructured":"Katoh T, Kawashima K, Fukuba N, et al. Low-dose rectal diclofenac does not prevent post-ERCP pancreatitis in low- or high-risk patients. J Gastroenterol Hepatol 2020;35:1247\u20131253.","journal-title":"J Gastroenterol Hepatol"},{"key":"8565_CR13","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/S0140-6736(16)30310-5","volume":"387","author":"H Luo","year":"2016","unstructured":"Luo H, Zhao L, Leung J, et al. Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial. Lancet 2016;387:2293\u20132301.","journal-title":"Lancet"},{"key":"8565_CR14","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1053\/j.gastro.2016.04.048","volume":"151","author":"NR Thiruvengadam","year":"2016","unstructured":"Thiruvengadam NR, Forde KA, Ma GK, et al. Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography. Gastroenterology 2016;151:288-297.e284.","journal-title":"Gastroenterology"},{"key":"8565_CR15","doi-asserted-by":"crossref","unstructured":"Levenick JM, Gordon SR, Fadden LL, et al. Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients. Gastroenterology 2016, 150:911\u2013917; quiz e919.","DOI":"10.1053\/j.gastro.2015.12.040"},{"key":"8565_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.gie.2016.08.034","volume":"85","author":"S Inamdar","year":"2017","unstructured":"Inamdar S, Han D, Passi M, Sejpal DV, Trindade AJ. Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk patients but not average-risk patients: a systematic review and meta-analysis. Gastrointest Endosc 2017;85:67\u201375.","journal-title":"Gastrointest Endosc"},{"key":"8565_CR17","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.gie.2016.10.004","volume":"85","author":"XK He","year":"2017","unstructured":"He XK, Sun LM. Does rectal indomethacin prevent post-ERCP pancreatitis in average-risk patients? Gastrointest Endosc 2017;85:687.","journal-title":"Gastrointest Endosc"},{"key":"8565_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/den.12787","volume":"29","author":"C Shen","year":"2017","unstructured":"Shen C, Shi Y, Su P. Is rectal indomethacin ineffective in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in the general population? Dig Endosc 2017;29:383\u2013384.","journal-title":"Dig Endosc"},{"key":"8565_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12876-015-0314-2","volume":"15","author":"VF Andrade-Davila","year":"2015","unstructured":"Andrade-Davila VF, Chavez-Tostado M, Davalos-Cobian C, et al. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial. BMC Gastroenterol 2015;15:85.","journal-title":"BMC Gastroenterol"},{"key":"8565_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.17235\/reed.2020.6502\/2019","volume":"112","author":"M Lindo Ricce","year":"2020","unstructured":"Lindo Ricce M, Rodr\u00edguez L\u00f3pez-Salazar T, Mendoza Jim\u00e9nez-Ridruejo J, Moreno Monteagudo JA, Santander Vaquero C. Effectiveness of rectal indomethacin in the prevention of acute pancreatitis after endoscopic retrograde cholangiopancreatography in unselected patients. Rev Esp Enferm Dig 2020;112:183\u2013188.","journal-title":"Rev Esp Enferm Dig"},{"key":"8565_CR21","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1556\/OH.2012.29403","volume":"153","author":"Z D\u00f6br\u00f6nte","year":"2012","unstructured":"D\u00f6br\u00f6nte Z, Toldy E, M\u00e1rk L, Sarang K, Hetilap LLJO: Effects of rectal indomethacin in the prevention of post-ERCP acute pancreatitis. Orv Hetilap. 2012;153:990\u2013996.","journal-title":"Orvosi Hetilap"},{"key":"8565_CR22","doi-asserted-by":"crossref","unstructured":"Levenick JM, Gordon SR, Fadden LL et al. Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients. Gastroenterology 2016, 150:911\u2013917; quiz e919.","DOI":"10.1053\/j.gastro.2015.12.040"},{"key":"8565_CR23","first-page":"e332","volume":"170","author":"G Geraci","year":"2019","unstructured":"Geraci G, Palumbo VD, D\u2019Orazio B, Maffongelli A, Fazzotta S, Lo Monte AI. Rectal Diclofenac administration for prevention of post-Endoscopic Retrograde Cholangio-Pancreatography (ERCP) acute pancreatitis. Randomized prospective study. Clin Ter 2019;170:e332\u2013e336.","journal-title":"Clin Ter"},{"key":"8565_CR24","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/ejp.1515","volume":"24","author":"NS Kumar","year":"2020","unstructured":"Kumar NS, Muktesh G, Samra T, et al. Comparison of efficacy of diclofenac and tramadol in relieving pain in patients of acute pancreatitis: A randomized parallel group double blind active controlled pilot study. Eur J Pain 2020;24:639\u2013648.","journal-title":"Eur J Pain"},{"key":"8565_CR25","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1007\/s11605-022-05399-6","volume":"26","author":"X Kang","year":"2022","unstructured":"Kang X, Guo X, Chen Z, et al. The Incidence and Severity of Post-ERCP Pancreatitis in Patients Receiving Standard Administration of NSAIDs: a Systematic Review and Meta-analysis. J Gastrointest Surg 2022;26:2380\u20132389.","journal-title":"J Gastrointest Surg"},{"key":"8565_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/MCG.0000000000001322","volume":"54","author":"J Yang","year":"2020","unstructured":"Yang J, Wang W, Liu C, Zhao Y, Ren M, He S. Rectal Nonsteroidal Anti-Inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention: A Network Meta-Analysis. J Clin Gastroenterol 2020;54:305\u2013313.","journal-title":"J Clin Gastroenterol"},{"key":"8565_CR27","doi-asserted-by":"publisher","first-page":"E477","DOI":"10.1055\/a-0862-0215","volume":"7","author":"JPR Serrano","year":"2019","unstructured":"Serrano JPR, de Moura DTH, Bernardo WM et al. Nonsteroidal anti-inflammatory drugs versus placebo for post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis. Endosc Int Open 2019;7:E477-e486.","journal-title":"Endosc Int Open"},{"key":"8565_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4253\/wjge.v12.i11.469","volume":"12","author":"JPR Serrano","year":"2020","unstructured":"Serrano JPR, Jukemura J, Romanini SG, et al. Nonsteroidal anti-inflammatory drug effectivity in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis. World J Gastrointest Endosc 2020;12:469\u2013487.","journal-title":"World J Gastrointest Endosc"},{"key":"8565_CR29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12876-018-0837-4","volume":"18","author":"Y Lyu","year":"2018","unstructured":"Lyu Y, Cheng Y, Wang B, Xu Y, Du W. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials. BMC Gastroenterol 2018;18:106.","journal-title":"BMC Gastroenterol"},{"key":"8565_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/MPG.0000000000002524","volume":"70","author":"DM Troendle","year":"2020","unstructured":"Troendle DM, Gurram B, Huang R, Barth BA. IV Ibuprofen for Prevention of Post-ERCP Pancreatitis in Children: A Randomized Placebo-controlled Feasibility Study. J Pediatr Gastroenterol Nutr 2020;70:121\u2013126.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"8565_CR31","doi-asserted-by":"publisher","first-page":"511","DOI":"10.29271\/jcpsp.2019.06.511","volume":"29","author":"A Ari","year":"2019","unstructured":"Ari A, Gurbulak B, Okmen H, Tatar C, Idiz UO, Ucuncu MZ. Effect of Dexketoprofene Trometamol on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. J Coll Physicians Surg Pak 2019;29:511\u2013515.","journal-title":"J Coll Physicians Surg Pak"},{"key":"8565_CR32","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/MCG.0b013e3181eb600e","volume":"45","author":"V Bhatia","year":"2011","unstructured":"Bhatia V, Ahuja V, Acharya SK, Garg PK. A randomized controlled trial of valdecoxib and glyceryl trinitrate for the prevention of post-ERCP pancreatitis. J Clin Gastroenterol 2011;45:170\u2013176.","journal-title":"J Clin Gastroenterol"},{"key":"8565_CR33","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s00464-016-5234-x","volume":"31","author":"On\u00f3frio F de Quadros","year":"2017","unstructured":"de Quadros On\u00f3frio F, Lima JCP, Watte G et al. Prophylaxis of pancreatitis with intravenous ketoprofen in a consecutive population of ERCP patients: a randomized double-blind placebo-controlled trial. Surg Endosc 2017;31:2317\u20132324.","journal-title":"Surg Endosc"},{"key":"8565_CR34","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1007\/s00464-022-09718-5","volume":"37","author":"H Sakai","year":"2023","unstructured":"Sakai H, Iwai N, Sakagami J, et al. Rectal administration of low-dose diclofenac does not reduce post-endoscopic retrograde cholangiopancreatography pancreatitis: a propensity score matching analysis. Surg Endosc 2023;37:2698\u20132705.","journal-title":"Surg Endosc"},{"key":"8565_CR35","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/den.13828","volume":"33","author":"T Tomoda","year":"2021","unstructured":"Tomoda T, Kato H, Miyamoto K, et al. Efficacy of low dose rectal diclofenac for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: Propensity score-matched analysis. Digestive Endoscopy 2021;33:656\u2013662.","journal-title":"Digestive Endoscopy"},{"key":"8565_CR36","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1097\/MPA.0000000000001877","volume":"50","author":"A Takaori","year":"2021","unstructured":"Takaori A, Ikeura T, Hori Y, et al. Rectally Administered Low-Dose Diclofenac Has No Effect on Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Propensity Score Analysis. Pancreas 2021;50:1024\u20131029.","journal-title":"Pancreas"},{"key":"8565_CR37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S2468-1253(19)30337-1","volume":"5","author":"EL Fogel","year":"2020","unstructured":"Fogel EL, Lehman GA, Tarnasky P, et al. Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial. Lancet Gastroenterol Hepatol 2020;5:132\u2013141.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"8565_CR38","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015742","volume":"98","author":"JH Lai","year":"2019","unstructured":"Lai JH, Hung CY, Chu CH. A randomized trial comparing the efficacy of single-dose and double-dose administration of rectal indomethacin in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis. Medicine (Baltimore) 2019;98:e15742.","journal-title":"Medicine (Baltimore)"},{"key":"8565_CR39","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.gie.2017.01.033","volume":"85","author":"\u00c1 Patai","year":"2017","unstructured":"Patai \u00c1, Solymosi N, Moh\u00e1csi L, Patai \u00c1V. Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials. Gastrointest Endosc 2017;85:1144-1156.e1141.","journal-title":"Gastrointest Endosc"},{"key":"8565_CR40","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1007\/s11605-018-3967-7","volume":"23","author":"L Liu","year":"2019","unstructured":"Liu L, Li C, Huang Y, Jin H. Nonsteroidal Anti-inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention: a Systematic Review and Meta-analysis. J Gastrointest Surg 2019;23:1991\u20132001.","journal-title":"J Gastrointest Surg"},{"key":"8565_CR41","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/MPA.0000000000000326","volume":"44","author":"T Rustagi","year":"2015","unstructured":"Rustagi T, Njei B. Factors Affecting the Efficacy of Nonsteroidal Anti-inflammatory Drugs in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Systematic Review and Meta-analysis. Pancreas 2015;44:859\u2013867.","journal-title":"Pancreas"},{"key":"8565_CR42","first-page":"538","volume":"19","author":"M Hosseini","year":"2016","unstructured":"Hosseini M, Shalchiantabrizi P, Yektaroudy K, Dadgarmoghaddam M, Salari M. Prophylactic Effect of Rectal Indomethacin Administration, with and without Intravenous Hydration, on Development of Endoscopic Retrograde Cholangiopancreatography Pancreatitis Episodes: A Randomized Clinical Trial. Archives of Iranian Medicine 2016;19:538\u2013543.","journal-title":"Archives of Iranian Medicine"},{"key":"8565_CR43","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.gie.2016.10.033","volume":"85","author":"SRS Mok","year":"2017","unstructured":"Mok SRS, Ho HC, Shah P, Patel M, Gaughan JP, Elfant AB. Lactated Ringer\u2019s solution in combination with rectal indomethacin for prevention of post-ERCP pancreatitis and readmission: a prospective randomized, double-blinded, placebo-controlled trial. Gastrointestinal Endoscopy 2017;85:1005\u20131013.","journal-title":"Gastrointestinal Endoscopy"},{"key":"8565_CR44","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.gie.2017.05.022","volume":"86","author":"J Buxbaum","year":"2017","unstructured":"Buxbaum J, Yu CY. Indomethacin and lactated Ringer\u2019s hydration to prevent post-ERCP pancreatitis: right combination but wrong volume. Gastrointestinal Endoscopy 2017;86:925\u2013926.","journal-title":"Gastrointestinal Endoscopy"},{"key":"8565_CR45","first-page":"S81","volume":"13","author":"MA Pasha","year":"2020","unstructured":"Pasha MA, Eslami P, Moghadam AD et al. The synergistic impact of NSAIDs and aggressive hydration therapy on the rate of post-ERCP pancreatitis in high -risk and low -risk patients. Gastroenterology and Hepatology from Bed to Bench 2020;13:S81\u2013S88.","journal-title":"Gastroenterology and Hepatology from Bed to Bench"},{"key":"8565_CR46","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S2468-1253(21)00057-1","volume":"6","author":"CJ Sperna Weiland","year":"2021","unstructured":"Sperna Weiland CJ, Smeets X, Kievit W et al. Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial. Lancet Gastroenterol Hepatol 2021;6:350\u2013358.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"8565_CR47","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1007\/s11605-022-05352-7","volume":"26","author":"F Du","year":"2022","unstructured":"Du F, Zhang Y, Yang X, et al. Efficacy of Combined Management with Nonsteroidal Anti-inflammatory Drugs for Prevention of Pancreatitis After Endoscopic Retrograde Cholangiography: a Bayesian Network Meta-analysis. J Gastrointest Surg 2022;26:1982\u20131997.","journal-title":"J Gastrointest Surg"},{"key":"8565_CR48","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.gie.2022.10.005","volume":"97","author":"JL Buxbaum","year":"2023","unstructured":"Buxbaum JL, Freeman M, Amateau SK et al. American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: summary and recommendations. Gastrointest Endosc 2023;97:153\u2013162.","journal-title":"Gastrointest Endosc"},{"key":"8565_CR49","doi-asserted-by":"publisher","first-page":"87","DOI":"10.18528\/ijgii220043","volume":"12","author":"VM Sharma","year":"2023","unstructured":"Sharma VM, Mathur A, Goyal MB, Jat SL. The role of rectal diclofenac and aggressive hydration with Ringer\u2019s lactate in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients. International Journal of Gastrointestinal Intervention 2023;12:87\u201392.","journal-title":"International Journal of Gastrointestinal Intervention"},{"key":"8565_CR50","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/MCG.0000000000001712","volume":"57","author":"P Guha","year":"2023","unstructured":"Guha P, Patra PS, Misra D et al. An Open-Label Randomized Controlled Trial Comparing Effectiveness of Aggressive Hydration Versus High-dose Rectal Indomethacin in the Prevention of Postendoscopic Retrograde Cholangiopancreatographic Pancreatitis (AHRI-PEP). Journal of Clinical Gastroenterology 2023;57:524\u2013530.","journal-title":"Journal of Clinical Gastroenterology"},{"key":"8565_CR51","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1007\/s12664-022-01269-w","volume":"41","author":"V Sharma","year":"2022","unstructured":"Sharma V, Mathur A. Comparative study of individual versus combination therapy of rectal diclofenac and intravenous ringer\u2019s lactate in prevention of post endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients. Indian Journal of Gastroenterology 2022;41:S150.","journal-title":"Indian Journal of Gastroenterology"},{"key":"8565_CR52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ajg.2022.01.004","volume":"23","author":"HE Makhzangy","year":"2022","unstructured":"Makhzangy HE, Samy S, Shehata M, Albuhiri A, Khairy A. Combined rectal indomethacin and intravenous saline hydration in post-ERCP pancreatitis prophylaxis. Arab J Gastroenterol 2022;23:95\u2013101.","journal-title":"Arab J Gastroenterol"},{"key":"8565_CR53","first-page":"1236","volume":"50","author":"R Thanage","year":"2021","unstructured":"Thanage R, Jain S, Chandnani S et al. Is the Combination of Rectal Diclofenac and Intravenous Ringer Lactate Superior to Individual Therapy for Prophylaxis of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Prospective, Open-Label. Single-Center Randomized Trial. Pancreas 2021;50:1236\u20131242.","journal-title":"Single-Center Randomized Trial. Pancreas"},{"key":"8565_CR54","first-page":"S6","volume":"53","author":"K Amalou","year":"2021","unstructured":"Amalou K, Belghanem F, Bousseloub A, Ararem I, Kezoula D, Medkour MT. Lactated Ringer\u2019s solution in combination with rectal indomethacin for prevention ofpost-ERCP pancreatitis: A prospective randomized, double-blinded, controlled trial. Endoscopy 2021;53:S6.","journal-title":"Endoscopy"},{"key":"8565_CR55","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/1751-2980.13158","volume":"23","author":"JH Yi","year":"2022","unstructured":"Yi JH, Li ZS, Hu LH. Pancreatic duct stents. J Dig Dis 2022;23:675\u2013686.","journal-title":"J Dig Dis"},{"key":"8565_CR56","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/ajg.2012.442","volume":"108","author":"BJ Elmunzer","year":"2013","unstructured":"Elmunzer BJ, Higgins PD, Saini SD et al. Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data. Am J Gastroenterol 2013;108:410\u2013415.","journal-title":"Am J Gastroenterol"},{"key":"8565_CR57","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000001281","volume":"48","author":"MM Abdelfatah","year":"2019","unstructured":"Abdelfatah MM, Gochanour E, Koutlas NJ, Othman MO. Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: Single Versus Dual Prophylactic Modalities. Pancreas 2019;48:e24.","journal-title":"Pancreas"},{"key":"8565_CR58","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1111\/jgh.15402","volume":"36","author":"X Wang","year":"2021","unstructured":"Wang X, Luo H, Luo B et al. Combination prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in patients undergoing double-guidewire assisted biliary cannulation: A case-control study with propensity score matching. J Gastroenterol Hepatol 2021;36:1905\u20131912.","journal-title":"J Gastroenterol Hepatol"},{"key":"8565_CR59","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/MPA.0000000000002090","volume":"51","author":"T Koshitani","year":"2022","unstructured":"Koshitani T, Konaka Y, Ohishi T et al. Prophylaxis of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Using Temporary Pancreatic Stents Versus Rectal Nonsteroidal Anti-inflammatory Drugs: A Randomized Controlled Trial. Pancreas 2022;51:663\u2013670.","journal-title":"Pancreas"},{"key":"8565_CR60","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1055\/a-0977-3119","volume":"51","author":"R Sotoudehmanesh","year":"2019","unstructured":"Sotoudehmanesh R, Ali-Asgari A, Khatibian M et al. Pharmacological prophylaxis versus pancreatic duct stenting plus pharmacological prophylaxis for prevention of post-ERCP pancreatitis in high risk patients: a randomized trial. Endoscopy 2019;51:915\u2013921.","journal-title":"Endoscopy"},{"key":"8565_CR61","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1007\/s10620-015-3643-7","volume":"60","author":"AA Siddiqui","year":"2015","unstructured":"Siddiqui AA, Patel D, Kaplan J et al. A Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in Patients with Suspected Type 3 Sphincter of Oddi Dysfunction. Digestive Diseases and Sciences 2015;60:2509\u20132515.","journal-title":"Digestive Diseases and Sciences"},{"key":"8565_CR62","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/ajg.2012.442","volume":"108","author":"BJ Elmunzer","year":"2013","unstructured":"Elmunzer BJ, Higgins PDR, Saini SD et al. Does Rectal Indomethacin Eliminate the Need for Prophylactic Pancreatic Stent Placement in Patients Undergoing High-Risk ERCP? <i>Post hoc<\/i> Efficacy and Cost-Benefit Analyses Using Prospective Clinical Trial Data. American Journal of Gastroenterology 2013;108:410\u2013415.","journal-title":"American Journal of Gastroenterology"},{"key":"8565_CR63","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1055\/s-0031-1291440","volume":"44","author":"P Katsinelos","year":"2012","unstructured":"Katsinelos P, Fasoulas K, Paroutoglou G et al. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial. Endoscopy 2012;44:53\u201359.","journal-title":"Endoscopy"},{"key":"8565_CR64","doi-asserted-by":"publisher","first-page":"8964","DOI":"10.12659\/MSM.911914","volume":"24","author":"J Wang","year":"2018","unstructured":"Wang J, Shen Y, Zhong Z, Wu S, Zheng L. Risk Factors for Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis and the Effect of Octreotide Combined with Nonsteroidal Anti-Inflammatory Drugs on Preventing Its Occurrence. Med Sci Monit 2018;24:8964\u20138969.","journal-title":"Med Sci Monit"},{"key":"8565_CR65","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.11569\/wcjd.v29.i21.1222","volume":"29","author":"ZX Wu","year":"2021","unstructured":"Wu ZX, Wang GL, Qiu P, Gong M, Li X, Wen JB. Selective indications of indomethacin and somatostatin, alone or in combination, and their preventive effects in patients at high risk for post-ERCP pancreatitis. World Chinese Journal of Digestology 2021;29:1222\u20131229.","journal-title":"World Chinese Journal of Digestology"},{"key":"8565_CR66","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/SLE.0000000000001202","volume":"33","author":"ZX Wu","year":"2023","unstructured":"Wu ZX, Xiao G, Wang GL, Xiong LM, Qiu P, Tan SP. Effects of Somatostatin and Indomethacin Mono or Combination Therapy on High-risk Hyperamylasemia and Post-pancreatitis Endoscopic Retrograde Cholangiopancreatography Patients: A Randomized Study. Surgical Laparoscopy Endoscopy & Percutaneous Techniques 2023;33:474\u2013479.","journal-title":"Surgical Laparoscopy Endoscopy & Percutaneous Techniques"},{"key":"8565_CR67","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1053\/j.gastro.2019.01.267","volume":"156","author":"T Tomoda","year":"2019","unstructured":"Tomoda T, Kato H, Ueki T et al. Combination of Diclofenac and Sublingual Nitrates Is Superior to Diclofenac Alone in Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography. Gastroenterology 2019;156:1753-1760.e1751.","journal-title":"Gastroenterology"},{"key":"8565_CR68","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.21037\/apm-20-1963","volume":"9","author":"Y Wang","year":"2020","unstructured":"Wang Y, Xu B, Zhang W et al. Prophylactic effect of rectal indomethacin plus nitroglycerin administration for preventing pancreatitis after endoscopic retrograde cholangiopancreatography in female patients. Ann Palliat Med 2020;9:4029\u20134037.","journal-title":"Ann Palliat Med"},{"key":"8565_CR69","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/ajg.2014.9","volume":"109","author":"R Sotoudehmanesh","year":"2014","unstructured":"Sotoudehmanesh R, Eloubeidi MA, Asgari AA, Farsinejad M, Khatibian M. A Randomized Trial of Rectal Indomethacin and Sublingual Nitrates to Prevent Post-ERCP Pancreatitis. American Journal of Gastroenterology 2014;109:903\u2013909.","journal-title":"American Journal of Gastroenterology"},{"key":"8565_CR70","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s10620-022-07518-4","volume":"68","author":"Chehade N El Hage","year":"2023","unstructured":"El Hage Chehade N, Ghoneim S, Shah S et al. Combination Topical Epinephrine and Non-steroidal Inflammatory Drugs in the Prevention of Post-ERCP Pancreatitis: A Systematic Review. Dig Dis Sci 2023;68:957\u2013968.","journal-title":"Dig Dis Sci"},{"key":"8565_CR71","doi-asserted-by":"crossref","unstructured":"Karami M, Salemi B, Ardestani MS: Determination of the effectiveness of epinephrine spray on the papillae in preventing pancreatitis after endoscopic retrograde cholangiopancreatography. Advanced Biomedical Research 2023, 12.","DOI":"10.4103\/abr.abr_321_21"},{"key":"8565_CR72","doi-asserted-by":"crossref","unstructured":"Romano-Munive AF, Garc\u00eda-Correa JJ, Garc\u00eda-Contreras LF et al: Can topical epinephrine application to the papilla prevent pancreatitis after endoscopic retrograde cholangiopancreatography? Results from a double blind, multicentre, placebo controlled, randomised clinical trial. BMJ Open Gastroenterology 2021, 8.","DOI":"10.1136\/bmjgast-2020-000562"},{"key":"8565_CR73","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s12664-021-01161-z","volume":"40","author":"HA Dar","year":"2021","unstructured":"Dar HA, Shah A, Javid G et al. Randomized trial of high-dose rectal diclofenac suppository and epinephrine spray on duodenal papilla for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Indian Journal of Gastroenterology 2021;40:483\u2013491.","journal-title":"Indian Journal of Gastroenterology"},{"key":"8565_CR74","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.cgh.2018.10.043","volume":"17","author":"H Luo","year":"2019","unstructured":"Luo H, Wang X, Zhang R et al. Rectal Indomethacin and Spraying of Duodenal Papilla With Epinephrine Increases Risk of Pancreatitis Following Endoscopic Retrograde Cholangiopancreatography. Clin Gastroenterol Hepatol 2019;17:1597-1606.e1595.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8565_CR75","doi-asserted-by":"publisher","first-page":"339","DOI":"10.14309\/ajg.0000000000000049","volume":"114","author":"A Kamal","year":"2019","unstructured":"Kamal A, Akshintala VS, Talukdar R et al. A Randomized Trial of Topical Epinephrine and Rectal Indomethacin for Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients. Am J Gastroenterol 2019;114:339\u2013347.","journal-title":"Am J Gastroenterol"},{"key":"8565_CR76","doi-asserted-by":"crossref","unstructured":"Dumonceau JM, Rigaux J, Kahaleh M, Gomez CM, Vandermeeren A, Devi\u00e8re J: Prophylaxis of post-ERCP pancreatitis: a practice survey. Gastrointest Endosc 2010, 71(6):934\u2013939, 939.e931\u2013932.","DOI":"10.1016\/j.gie.2009.10.055"},{"key":"8565_CR77","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.gie.2023.01.049","volume":"97","author":"M Ashat","year":"2023","unstructured":"Ashat M, Kandula S, Cote GA et al. Utilization pattern of prophylactic measures for prevention of post-ERCP pancreatitis: a National Survey Study. Gastrointest Endosc 2023;97:1059-1066.e1053.","journal-title":"Gastrointest Endosc"},{"key":"8565_CR78","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.14309\/01.ajg.0000772128.62640.f2","volume":"116","author":"CS Tailor","year":"2021","unstructured":"Tailor CS, Chauhan S, Kiran B et al. Knowledge, attitude, and the practices in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) among advanced endoscopists. American Journal of Gastroenterology 2021;116:S17.","journal-title":"American Journal of Gastroenterology"},{"key":"8565_CR79","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1007\/s10620-020-06796-0","volume":"66","author":"CJ Sperna Weiland","year":"2021","unstructured":"Sperna Weiland CJ, Engels MML, Poen AC et al. Increased Use of Prophylactic Measures in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Dig Dis Sci 2021;66:4457\u20134466.","journal-title":"Dig Dis Sci"},{"key":"8565_CR80","doi-asserted-by":"publisher","first-page":"934","DOI":"10.14309\/ajg.0000000000000623","volume":"115","author":"ZL Smith","year":"2020","unstructured":"Smith ZL, Elmunzer BJ, Cooper GS, Chak A. Real-World Practice Patterns in the Era of Rectal Indomethacin for Prophylaxis Against Post-ERCP Pancreatitis in a High-Risk Cohort. Am J Gastroenterol 2020;115:934\u2013940.","journal-title":"Am J Gastroenterol"},{"key":"8565_CR81","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.14309\/01.ajg.0000589840.22236.1c","volume":"114","author":"J Hyder","year":"2019","unstructured":"Hyder J, Srinivasan S, Hussein Agha Y, Wuthnow C, Salyers W, Tofteland N. Post-ERCP pancreatitis rates and NSAID use in a community Hospital. American Journal of Gastroenterology 2019;114:S46.","journal-title":"American Journal of Gastroenterology"},{"key":"8565_CR82","doi-asserted-by":"publisher","first-page":"E979","DOI":"10.1055\/a-1460-7776","volume":"9","author":"A Issak","year":"2021","unstructured":"Issak A, Elangovan A, Ferguson RD, Waghray N, Sandhu DS. Underutilization of prophylactic rectal indomethacin and pancreatic duct stent for prevention of post-ERCP Pancreatitis. Endoscopy International Open 2021;9:E979\u2013E985.","journal-title":"Endoscopy International Open"},{"key":"8565_CR83","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.gie.2019.11.013","volume":"91","author":"P Avila","year":"2020","unstructured":"Avila P, Holmes I, Kouanda A, Arain M, Dai SC. Practice patterns of post-ERCP pancreatitis prophylaxis techniques in the United States: a survey of advanced endoscopists. Gastrointest Endosc 2020;91:568-573.e562.","journal-title":"Gastrointest Endosc"},{"key":"8565_CR84","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000487150","volume":"26","author":"L Lopes","year":"2018","unstructured":"Lopes L, Canena J. ERCP in Portugal: A Wide Survey on the Prevention of Post-ERCP Pancreatitis and Papillary Cannulation Techniques. GE Port J Gastroenterol 2018;26:14\u201323.","journal-title":"GE Port J Gastroenterol"},{"key":"8565_CR85","doi-asserted-by":"crossref","unstructured":"Riesco JM, Perez-Miranda M, Gonz\u00e1lez-Huix F, Alvarez A, P\u00e9rez-Rold\u00e1n F, Gornals J: High compliance with guideline recommendations on post-ERCP pancreatitis (PEP) prevention is associated with low pep incidence: Results from a national Spanish survey. Gastrointestinal Endoscopy 2016, 83(5):AB244.","DOI":"10.1016\/j.gie.2016.03.343"},{"key":"8565_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(16)30098-6","volume":"48","author":"A Mariani","year":"2016","unstructured":"Mariani A, Anderloni A, Cengia G et al. Prospective community practice-based study of ercp quality. Digestive and Liver Disease 2016;48:e108.","journal-title":"Digestive and Liver Disease"},{"key":"8565_CR87","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/flgastro-2013-100323","volume":"5","author":"MS Hanna","year":"2014","unstructured":"Hanna MS, Portal AJ, Dhanda AD, Przemioslo R. UK wide survey on the prevention of post-ERCP pancreatitis. Frontline Gastroenterology 2014;5:103\u2013110.","journal-title":"Frontline Gastroenterology"},{"key":"8565_CR88","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/MPA.0000000000000245","volume":"44","author":"D Nicol\u00e1s-P\u00e9rez","year":"2015","unstructured":"Nicol\u00e1s-P\u00e9rez D, Castilla-Rodr\u00edguez I, Gimeno-Garc\u00eda AZ, Romero-Garc\u00eda R, N\u00fa\u00f1ez-D\u00edaz V, Quintero E. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a cost-effectiveness analysis. Pancreas 2015;44:204\u2013210.","journal-title":"Pancreas"},{"key":"8565_CR89","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cgh.2021.08.050","volume":"20","author":"NR Thiruvengadam","year":"2022","unstructured":"Thiruvengadam NR, Saumoy M, Schneider Y et al. A Cost-Effectiveness Analysis for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Prophylaxis in the United States. Clin Gastroenterol Hepatol 2022;20:216-226.e242.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8565_CR90","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1053\/j.gastro.2022.05.026","volume":"163","author":"K McKee","year":"2022","unstructured":"McKee K, Singh VK, Akshintala VS. Rectal Nonsteroidal Anti-inflammatory Drugs for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Prophylaxis: A Case Study in a Price-Escalation Era. Gastroenterology 2022;163:543\u2013546.","journal-title":"Gastroenterology"},{"key":"8565_CR91","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.gie.2019.09.008","volume":"91","author":"AC Storm","year":"2020","unstructured":"Storm AC, Abu Dayyeh BK, Petersen BT et al. Indomethacin for post-ERCP pancreatitis: Prophylaxis at what cost? Gastrointest Endosc 2020;91:207\u2013208.","journal-title":"Gastrointest Endosc"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08565-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08565-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08565-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:26:13Z","timestamp":1732580773000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08565-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,5]]},"references-count":91,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["8565"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08565-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,5]]},"assertion":[{"value":"5 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We obtained written consent from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}